|
Market Closed -
Other stock markets
|
Pre-market 14:16:53 | |||
| 76.56 USD | +3.74% |
|
75.96 | -0.78% |
| 07-09 | Moderna wins EU contract for RSV vaccine supply | RE |
| 07-09 | UK Life Sciences Hits GBP3 Billion Investment Milestone | MT |
| Market Cap | 30.38B 26.57B 24.51B 22.67B 43.04B 2,900B 43.76B 293B 115B 1,424B 114B 112B 4,932B | P/E 2026 * |
-8.83x | P/E 2027 * | -16.1x |
|---|---|---|---|---|---|
| Enterprise Value | 26.97B 23.6B 21.76B 20.13B 38.21B 2,575B 38.85B 261B 102B 1,264B 101B 99.07B 4,379B | EV / Sales 2026 * |
12.9x | EV / Sales 2027 * | 11.1x |
| Free-Float |
92.69% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Moderna, Inc.
| 1 day | +3.74% | ||
| 1 week | -4.01% | ||
| Current month | +9.32% | ||
| 1 month | +60.40% | ||
| 3 months | +49.30% | ||
| 6 months | +123.21% | ||
| Current year | +159.61% |
| 1 week | 73.14 |  | 85.6 |
| 1 month | 46.3 | | 85.6 |
| Current year | 29.81 | | 85.6 |
| 1 year | 22.28 | | 85.6 |
| 3 years | 22.28 | | 170.47 |
| 5 years | 22.28 | | 497.49 |
| 10 years | 11.54 | | 497.49 |
| Manager | Title | Age | Since |
|---|---|---|---|
Stéphane Bancel
CEO | Chief Executive Officer | 54 | 01/03/2011 |
James Mock
DFI | Director of Finance/CFO | 49 | 06/09/2022 |
Stephen Hoge
PSD | President | 50 | 01/11/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Noubar Afeyan
CHM | Chairman | 63 | 01/02/2012 |
Stéphane Bancel
BRD | Director/Board Member | 54 | 01/03/2011 |
Francois Nader
BRD | Director/Board Member | 69 | 11/12/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 07-05 | Free | Executive/Senior Manager | 57,022 | 0.0144% | ||
| 07-02 | Fiscal year | Chief Financial Officer | 3,607 | 0.0009% | ||
| 06-15 | Fiscal year | Chairperson | 160,008 | 0.0403% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.74% | -4.01% | +133.49% | -35.59% | 30.38B | |
| +0.76% | +2.09% | +20.88% | -3.54% | 67.96B | |
| +0.32% | -3.24% | +45.48% | +220.12% | 54.4B | |
| -2.10% | +0.89% | -49.30% | -53.47% | 41.74B | |
| -2.79% | +32.50% | +32.50% | +32.50% | 40.63B | |
| -0.72% | -7.96% | +49.53% | -27.69% | 29.37B | |
| +1.07% | +1.42% | +72.47% | +90.95% | 23.68B | |
| +3.88% | +2.16% | +11.78% | +201.51% | 19.15B | |
| +15.12% | +16.82% | +96.11% | +433.87% | 17.68B | |
| +0.04% | +0.29% | +64.18% | +135.26% | 17.14B | |
| Average | +1.95% | +0.53% | +47.71% | +99.39% | 34.21B | |
| Weighted average by Cap. | +0.98% | -0.36% | +39.18% | +72.87% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.09B 1.83B 1.69B 1.56B 2.97B 200B 3.02B 20.23B 7.93B 98.13B 7.86B 7.69B 340B | 2.55B 2.23B 2.06B 1.9B 3.61B 243B 3.67B 24.63B 9.66B 120B 9.57B 9.37B 414B |
| Net income | -3.41B -2.98B -2.75B -2.55B -4.83B -326B -4.91B -32.95B -12.92B -160B -12.8B -12.53B -554B | -1.85B -1.62B -1.49B -1.38B -2.62B -177B -2.67B -17.87B -7.01B -86.73B -6.95B -6.8B -300B |
| Net Debt | -3.41B -2.98B -2.75B -2.54B -4.83B -325B -4.91B -32.9B -12.9B -160B -12.79B -12.51B -553B | -2.05B -1.8B -1.66B -1.53B -2.91B -196B -2.96B -19.83B -7.78B -96.23B -7.71B -7.54B -333B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/07/26 | $76.56 | +3.74% | 4,415,034 |
| 08/07/26 | $73.80 | -7.48% | 6,581,662 |
| 07/07/26 | $79.77 | -2.48% | 8,688,340 |
| 06/07/26 | $81.80 | +2.56% | 17,296,875 |
| 02/07/26 | $79.76 | +10.01% | 14,111,998 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MRNA Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
